TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 3 | 0 | -1 | 0 | 27 | -3 | -26 | -1 |
| S | %wins | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/15 17:51 | 6/15/15 | OCUL | Ocular Therapeutix, Inc | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | S | -7,040 | 22.00 | 7 | -320 | -13 | 2,215 | M | 22 | -48 | 2 | -5 | -6 | 0 | 2 | -3 | 10 | -26 | -58 | -72 | |||
6/11/15 17:24 | 6/10/15 | OCUL | Ocular Therapeutix, Inc | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | S | -9,394 | 22.00 | 6 | -427 | -14 | 2,535 | M | 16 | -49 | -7 | -14 | -8 | 2 | -1 | -1 | -8 | -23 | -60 | -73 | |||
7/31/14 17:53 | 7/29/14 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | S.d | -2,500 | 12.00 | 6 | -208 | -9 | 2,208 | D | 0 | 0 | 1 | -2 | 131 | 108 | 66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |